| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Revenue | $4.01B | +15.7% |
| Cost of Revenue | $2.33B | +17.5% |
| Gross Profit | $1.67B | +13.4% |
| R&D Expense | $95.1M | +7.7% |
| SG&A Expense | $1.16B | +11.4% |
| Operating Income | $509.7M | +19.2% |
| Interest Expense | $27.0M | +11.6% |
| Pre-tax Income | $493.9M | +24.7% |
| Income Tax | $109.9M |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $223.2M | -54.6% |
| Accounts Receivable | $665.9M | +16.5% |
| Inventory | $485.7M | +21.8% |
| Current Assets | $1.47B | -5.1% |
| Total Assets | $3.48B | -2.7% |
| Current Liabilities | $733.6M | +6.0% |
| Long-term Debt | $495.0M | +0.1% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $316.3M | -22.6% |
| Capital Expenditures | $56.5M | +29.0% |
| Investing Cash Flow | -$62.2M | +47.2% |
| Financing Cash Flow | -$512.4M | -41.3% |
| Free Cash Flow | $259.8M | -28.8% |
| +22.2% |
| Net Income | $384.0M | +25.4% |
| EPS (Basic) | $11.23 | +33.1% |
| EPS (Diluted) | $11.08 | +32.2% |
| Total Liabilities |
| $1.57B |
| +2.5% |
| Stockholders' Equity | $1.91B | -6.5% |